scholarly article | Q13442814 |
P356 | DOI | 10.1128/AAC.00630-16 |
P8608 | Fatcat ID | release_xkkfkthq6zf3dcwng5ebdjglvy |
P932 | PMC publication ID | 4958160 |
P698 | PubMed publication ID | 27297480 |
P50 | author | Boualem Sendid | Q55090913 |
Eric Dannaoui | Q56458995 | ||
Patrice Le Pape | Q61160079 | ||
Stéphane Ranque | Q85953888 | ||
Muriel Cornet | Q87315118 | ||
P2093 | author name string | A Datry | |
E Bailly | |||
J Guitard | |||
D Maubon | |||
J P Gangneux | |||
I Accoceberry | |||
C Hennequin | |||
J Chandenier | |||
M-E Bougnoux | |||
A Fekkar | |||
F Botterel | |||
A Dupuis | |||
S Chevrier | |||
F Dalle | |||
M Sautour | |||
Y Le Govic | |||
T Chouaki | |||
A Angoulvant | |||
P2860 | cites work | Echinocandin resistance: an emerging clinical problem? | Q28544739 |
Acquired resistance to echinocandins in Candida albicans: case report and review | Q34623936 | ||
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. | Q35140020 | ||
Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. | Q35635472 | ||
Candida spp. with acquired echinocandin resistance, France, 2004-2010. | Q35845865 | ||
Micafungin: pharmacology, experimental therapeutics and clinical applications | Q36120798 | ||
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006 | Q36424929 | ||
Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin. | Q36785949 | ||
Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin | Q37263358 | ||
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. | Q37544819 | ||
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. | Q38058556 | ||
Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management | Q38254290 | ||
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. | Q40345973 | ||
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media | Q41939680 | ||
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. | Q43271946 | ||
EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole | Q44013179 | ||
Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates | Q44120897 | ||
EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts | Q46812076 | ||
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? | Q46908055 | ||
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. | Q47643534 | ||
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on | Q59286587 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multicenter clinical trial | Q6934595 |
P1104 | number of pages | 4 | |
P304 | page(s) | 5088-5091 | |
P577 | publication date | 2016-07-22 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin | |
P478 | volume | 60 |
Q91817088 | Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait |
Q37528498 | Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance. |
Q37287777 | Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods |
Q37538775 | Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method |
Q58737037 | Susceptibility Testing of Fungi to Antifungal Drugs |
Search more.